Cisatracurium besylate Intravenous and Insulin Glargine (U-300) Pens
Determining the interaction of Cisatracurium besylate Intravenous and Insulin Glargine (U-300) Pens and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: cisatracurium
Brand name: Nimbex
Synonyms: Cisatracurium
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Cisatracurium besylate Intravenous-Insulin glargine and lixisenatide
- Cisatracurium besylate Intravenous-Insulin glargine and lixisenatide Subcutaneous
- Cisatracurium besylate Intravenous-Insulin glargine, recombinant Subcutaneous
- Cisatracurium besylate Intravenous-Insulin glulisine
- Cisatracurium besylate Intravenous-Insulin Glulisine (Cartridges and Pens)
- Cisatracurium besylate Intravenous-Insulin Glulisine (Vials)
- Insulin Glargine (U-300) Pens-Cisplatin
- Insulin Glargine (U-300) Pens-Cisplatin Intravenous
- Insulin Glargine (U-300) Pens-Citalopram
- Insulin Glargine (U-300) Pens-Citalopram Capsules
- Insulin Glargine (U-300) Pens-Citalopram Hydrobromide
- Insulin Glargine (U-300) Pens-Citalopram Oral Solution